Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 255

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 8
Chunk 255
---
 annual meeting of shareholders are referred to in our Articles of Association as extraordinary meetings.

The Companies Law provides that an extraordinary general meeting
of shareholders may be called by the board of directors as it deems fit. In addition, the board of directors is required to convene
an extraordinary general meeting of shareholders upon the written request of (i) two or more directors or 25% of the directors in office,
or (ii) one or more shareholders holding, in the aggregate, at least (a) 5% of the issued share capital and 1% of the voting rights; or
(b) 5% of the voting rights of the company.

The Companies Law requires that resolutions regarding the following
matters must be passed at a general meeting of our shareholders:

  amendments to our Articles of Association;  

  appointment, termination or the terms of service of our auditors;  

  appointment of external directors (if applicable);  

  approval of certain related party transactions;  

  increases or reductions of our authorized share capital;  
 ────────────────────────────────────────────────────────────

  a merger; and  

  the exercise of our board of directors’ powers by a general meeting, if our                                                       

93

Shareholders entitled to participate and vote at our general meetings
are the shareholders of record on a date to be determined by the board of directors, which, according to the Relief Regulations, as a
company dual listed on the TASE and the Nasdaq, may be between 4 and 60 days prior to the date of the meeting.

Under the Companies Law, shareholder meetings generally require
prior notice of not less than 21 days or, with respect to certain matters, such as election of directors and affiliated party transactions,
not less than 35 days. Only shareholders of record as reflected on our share register at the close of business on the date fixed by the
board of directors as the record date determining the then shareholders who will be entitled to vote, shall be entitled to notice of,
and to vote, in person or by proxy, at a general meeting and any postponement or adjournment thereof.

C. Material Contracts

We have not entered into any material contract within the two years
prior to the date of this Annual Report on Form 20-F, other than contracts entered into in the ordinary course of business, or as otherwise
described elsewhere in this Annual Report on Form 20-F.

D. Exchange Controls

There are currently no Israeli governmental laws, decrees or regulations